Targeting Biomolecules

“Targeting biomolecules" is a nonspecific term used to describe the process or strategy of designing drugs, probes, or technologies to interact selectively with *biologically relevant molecules*—such as proteins, nucleic acids, or carbohydrates—within living systems for therapeutic, diagnostic, or research purposes. Biomolecules include large classes like proteins, nucleic acids, lipids, and carbohydrates, each with distinct roles in physiology and disease. However, "Targeting biomolecules" does not correspond to any single, defined drug target or molecular entity; thus, it cannot be mapped to a unique molecule, abbreviation, or therapeutically actionable target[5][1][2].